ClinVar Genomic variation as it relates to human health
NM_000094.4(COL7A1):c.3840del (p.Gly1281fs)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_000094.4(COL7A1):c.3840del (p.Gly1281fs)
Variation ID: 372332 Accession: VCV000372332.38
- Type and length
-
Deletion, 1 bp
- Location
-
Cytogenetic: 3p21.31 3: 48585611 (GRCh38) [ NCBI UCSC ] 3: 48623044 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Jan 9, 2017 Oct 20, 2024 Jul 1, 2024 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_000094.4:c.3840del MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_000085.1:p.Gly1281fs frameshift NM_000094.3:c.3840delC NC_000003.12:g.48585612del NC_000003.11:g.48623045del NG_007065.1:g.14642del LRG_286:g.14642del LRG_286t1:c.3840del LRG_286p1:p.Gly1281fs - Protein change
- G1281fs
- Other names
- -
- Canonical SPDI
- NC_000003.12:48585610:GG:G
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
- -
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
COL7A1 | - | - |
GRCh38 GRCh37 |
5204 | 5236 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Pathogenic (4) |
criteria provided, multiple submitters, no conflicts
|
Jul 1, 2024 | RCV000413788.18 | |
Pathogenic (1) |
no assertion criteria provided
|
Feb 23, 2016 | RCV000477818.2 | |
Pathogenic (1) |
no assertion criteria provided
|
Sep 16, 2020 | RCV001272362.2 | |
Pathogenic (2) |
criteria provided, multiple submitters, no conflicts
|
Apr 1, 2022 | RCV002278635.2 | |
not provided (1) |
no classification provided
|
- | RCV003318573.1 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Pathogenic
(Mar 14, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Recessive dystrophic epidermolysis bullosa
Affected status: yes
Allele origin:
paternal
|
Center for Research in Genodermatoses and Epidermolysis Bullosa, University of Buenos Aires
Accession: SCV002499330.1
First in ClinVar: Aug 29, 2022 Last updated: Aug 29, 2022 |
Number of individuals with the variant: 1
Secondary finding: no
|
|
Pathogenic
(May 26, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Not Provided
Affected status: yes
Allele origin:
germline
|
GeneDx
Accession: SCV000490484.4
First in ClinVar: Jan 09, 2017 Last updated: Mar 04, 2023 |
Comment:
Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not … (more)
Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at a significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 28168442, 24317394, 20301481, 29500833, 29625052, 26689913, 34426522, 23786535, 16971478, 10504458) (less)
|
|
Pathogenic
(Nov 14, 2021)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
Revvity Omics, Revvity
Accession: SCV002019682.3
First in ClinVar: Nov 29, 2021 Last updated: Feb 04, 2024 |
|
|
Pathogenic
(Nov 06, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV000956457.5
First in ClinVar: Aug 14, 2019 Last updated: Feb 14, 2024 |
Comment:
This sequence change creates a premature translational stop signal (p.Gly1281Valfs*44) in the COL7A1 gene. It is expected to result in an absent or disrupted protein … (more)
This sequence change creates a premature translational stop signal (p.Gly1281Valfs*44) in the COL7A1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in COL7A1 are known to be pathogenic (PMID: 16971478). This variant is present in population databases (rs757688782, gnomAD 0.003%). This premature translational stop signal has been observed in individual(s) with epidermolysis bullosa dystrophica (PMID: 10504458, 16971478, 23786535, 24317394). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 372332). For these reasons, this variant has been classified as Pathogenic. (less)
|
|
Pathogenic
(Apr 01, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Recessive dystrophic epidermolysis bullosa
Affected status: yes
Allele origin:
paternal
|
Victorian Clinical Genetics Services, Murdoch Childrens Research Institute
Accession: SCV003921907.1
First in ClinVar: May 06, 2023 Last updated: May 06, 2023 |
Comment:
0103 - Dominant negative and loss of function are known mechanisms of disease in this gene and are associated with dystrophic epidermolysis bullosa (OMIM, PMID: … (more)
0103 - Dominant negative and loss of function are known mechanisms of disease in this gene and are associated with dystrophic epidermolysis bullosa (OMIM, PMID: 31670143). (I) 0108 - This gene is associated with both recessive and dominant disease. The spectrum of dystrophic epidermolysis bullosa associated with this gene can be either autosomal dominant or recessive inheritance. Autosomal dominant epidermolysis bullosa dystrophica (MIM#131750) is typically associated with milder phenotypes, whereas autosomal recessive epidermolysis bullosa dystrophica (MIM#226600) is usually observed in more severe cases (OMIM). Premature termination variants resulting in complete absence of protein are usually associated with the most severe recessive dystrophic epidermolysis bullosa (PMID: 32506467). (I) 0201 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (premature termination codon is located at least 54 nucleotides upstream of the final exon-exon junction). (SP) 0251 - This variant is heterozygous. (I) 0304 - Variant is present in gnomAD <0.01 (5 heterozygotes, 0 homozygotes). (SP) 0701 - Other premature termination variants comparable to the one identified in this case have very strong previous evidence for pathogenicity. Many NMD-predicted variants in this gene have been reported as likely pathogenic/pathogenic (ClinVar). (SP) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals. It has been reported in at least two individuals with recessive epidermolysis bullosa (PMIDs: 26446410, 23786535), and as pathogenic by multiple clinical testing laboratories (ClinVar). (SP) 1206 - This variant has been shown to be paternally inherited (by trio analysis). (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign (less)
|
|
Pathogenic
(Jul 01, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: yes
Allele origin:
germline
|
CeGaT Center for Human Genetics Tuebingen
Accession: SCV005092488.3
First in ClinVar: Aug 04, 2024 Last updated: Oct 20, 2024 |
Comment:
COL7A1: PM3:Very Strong, PVS1, PM2, PP4
Number of individuals with the variant: 1
|
|
Pathogenic
(Feb 23, 2016)
|
no assertion criteria provided
Method: research
|
Transient bullous dermolysis of the newborn
Affected status: unknown
Allele origin:
paternal
|
Division of Human Genetics, Children's Hospital of Philadelphia
Study: CSER-PediSeq
Accession: SCV000536812.1 First in ClinVar: Apr 23, 2017 Last updated: Apr 23, 2017 |
|
|
Pathogenic
(Sep 16, 2020)
|
no assertion criteria provided
Method: clinical testing
|
Autosomal recessive epidermolysis bullosa dystrophica inversa
Affected status: unknown
Allele origin:
germline
|
Natera, Inc.
Accession: SCV001454274.1
First in ClinVar: Jan 02, 2021 Last updated: Jan 02, 2021 |
|
|
not provided
(-)
|
no classification provided
Method: literature only
|
Generalized dominant dystrophic epidermolysis bullosa
Affected status: unknown
Allele origin:
germline
|
GeneReviews
Accession: SCV004023207.1
First in ClinVar: Aug 05, 2023 Last updated: Aug 05, 2023 |
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
Analysis of COL7A1 pathogenic variants in a large cohort of dystrophic epidermolysis bullosa patients from Argentina reveals a new genotype-phenotype correlation. | Natale MI | American journal of medical genetics. Part A | 2022 | PMID: 35979658 |
Dystrophic Epidermolysis Bullosa. | Adam MP | - | 2018 | PMID: 20301481 |
Patient-specific naturally gene-reverted induced pluripotent stem cells in recessive dystrophic epidermolysis bullosa. | Tolar J | The Journal of investigative dermatology | 2014 | PMID: 24317394 |
Late-onset pretibial recessive dystrophic epidermolysis bullosa. | Mahto A | Clinical and experimental dermatology | 2013 | PMID: 23786535 |
Epidermolysis bullosa. II. Type VII collagen mutations and phenotype-genotype correlations in the dystrophic subtypes. | Varki R | Journal of medical genetics | 2007 | PMID: 16971478 |
Comparative mutation detection screening of the type VII collagen gene (COL7A1) using the protein truncation test, fluorescent chemical cleavage of mismatch, and conformation sensitive gel electrophoresis. | Whittock NV | The Journal of investigative dermatology | 1999 | PMID: 10504458 |
Text-mined citations for rs757688782 ...
HelpRecord last updated Oct 20, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.